Y-mAbs Therapeutics
YMAB
#8247
Rank
A$0.28 B
Marketcap
$6.41
Share price
-0.73%
Change (1 day)
-71.94%
Change (1 year)

P/S ratio for Y-mAbs Therapeutics (YMAB)

P/S ratio as of April 2025 (TTM): 2.08

According to Y-mAbs Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.98. At the end of 2024 the company had a P/S ratio of 4.09.

P/S ratio history for Y-mAbs Therapeutics from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.0916.5%
20233.517.42%
20223.27-83.89%
202120.3-79.03%
202096.7
2019N/A
2018N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA